|
Volumn 2, Issue 9, 2006, Pages 457-
|
Patient-centered outcomes: A bridge too far?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRHEUMATIC AGENT;
TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR ANTIBODY;
CLINICAL EFFECTIVENESS;
DISEASE ASSOCIATION;
DRUG EFFICACY;
DRUG TARGETING;
EDITORIAL;
FIBROMYALGIA;
HUMAN;
MORTALITY;
OUTCOMES RESEARCH;
PATHOGENESIS;
PATIENT CARE;
PHYSICAL DISABILITY;
PREDICTION;
PRIORITY JOURNAL;
QUALITY OF LIFE;
REMISSION;
RHEUMATIC DISEASE;
RHEUMATOID ARTHRITIS;
RISK REDUCTION;
SYSTEMIC LUPUS ERYTHEMATOSUS;
WELLBEING;
HUMANS;
OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE);
PATIENT-CENTERED CARE;
RHEUMATIC DISEASES;
|
EID: 33748428185
PISSN: 17458382
EISSN: 17458390
Source Type: Journal
DOI: 10.1038/ncprheum0289 Document Type: Editorial |
Times cited : (4)
|
References (0)
|